COSCIENS Biopharma Statistics Share Statistics COSCIENS Biopharma has 3.15M
shares outstanding. The number of shares has increased by 0.99%
in one year.
Shares Outstanding 3.15M Shares Change (YoY) 0.99% Shares Change (QoQ) 0.75% Owned by Institutions (%) 0.86% Shares Floating 3.1M Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 18.41K, so 0.59% of the outstanding
shares have been sold short.
Short Interest 18.41K Short % of Shares Out 0.59% Short % of Float 0.59% Short Ratio (days to cover) 6.15
Valuation Ratios The PE ratio is -0.47 and the forward
PE ratio is null.
COSCIENS Biopharma's PEG ratio is
0.
PE Ratio -0.47 Forward PE n/a PS Ratio 0.78 Forward PS n/a PB Ratio 0.54 P/FCF Ratio -0.45 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for COSCIENS Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.32,
with a Debt / Equity ratio of 0.18.
Current Ratio 3.32 Quick Ratio 2.95 Debt / Equity 0.18 Debt / EBITDA -0.17 Debt / FCF -0.15 Interest Coverage -141.71
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $228.17K Profits Per Employee $-382.73K Employee Count 40 Asset Turnover 0.26 Inventory Turnover 1.81
Taxes Income Tax 84K Effective Tax Rate -0.55%
Stock Price Statistics The stock price has increased by -43.26% in the
last 52 weeks. The beta is 1.98, so COSCIENS Biopharma's
price volatility has been higher than the market average.
Beta 1.98 52-Week Price Change -43.26% 50-Day Moving Average 3.67 200-Day Moving Average 3.23 Relative Strength Index (RSI) 43.5 Average Volume (20 Days) 3,414
Income Statement In the last 12 months, COSCIENS Biopharma had revenue of 9.13M
and earned -15.31M
in profits. Earnings per share was -5.93.
Revenue 9.13M Gross Profit 4.73M Operating Income -18.28M Net Income -15.31M EBITDA -13.49M EBIT -15.1M Earnings Per Share (EPS) -5.93
Full Income Statement Balance Sheet The company has 16.39M in cash and 2.31M in
debt, giving a net cash position of 14.08M.
Cash & Cash Equivalents 16.39M Total Debt 2.31M Net Cash 14.08M Retained Earnings -12.11M Total Assets 31.14M Working Capital 13.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.57M
and capital expenditures -1.16M, giving a free cash flow of -15.73M.
Operating Cash Flow -14.57M Capital Expenditures -1.16M Free Cash Flow -15.73M FCF Per Share -6.09
Full Cash Flow Statement Margins Gross margin is 51.82%, with operating and profit margins of -200.29% and -167.74%.
Gross Margin 51.82% Operating Margin -200.29% Pretax Margin -166.82% Profit Margin -167.74% EBITDA Margin -147.8% EBIT Margin -200.29% FCF Margin -172.34%
Dividends & Yields CSCI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for CSCI.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 3, 2024. It was a
backward
split with a ratio of 1:4.
Last Split Date May 3, 2024 Split Type backward Split Ratio 1:4
Scores Altman Z-Score -1.33 Piotroski F-Score 1
